Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$662M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$116M |
| 3 |
Broadcom
AVGO
|
+$96.2M |
| 4 |
Walmart Inc
WMT
|
+$91.2M |
| 5 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$77.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Bitcoin Trust
IBIT
|
+$175M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$152M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$149M |
| 4 |
INFN
Infinera Corporation Common Stock
INFN
|
+$108M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$70.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.92% |
| 2 | Financials | 4.33% |
| 3 | Healthcare | 3.85% |
| 4 | Consumer Discretionary | 3.59% |
| 5 | Industrials | 3.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
NVR
NVR
$17B
| $6.16M | 0.02% |
+850
| New | +$6.46M |
|
702
Hamilton Insurance Group
HG
$3.46B
| $6.14M | 0.02% |
296,356
-76,394
| -20% | -$1.49M |
|
703
Altria Group
MO
$114B
| $6.14M | 0.02% |
+102,240
| New | +$5.58M |
|
704
Primerica
PRI
$9.23B
| $6.13M | 0.02% |
21,549
+14,640
| +212% | +$4.17M |
|
705
PUT
SoFi Technologies
SOFI
$23.9B
| $6.11M | 0.02% |
525,300
+289,500
| +123% | +$4.17M |
|
706
TTM Technologies
TTMI
$11.2B
| $6.1M | 0.02% |
297,505
+97,556
| +49% | +$2.36M |
|
707
Kinsale Capital Group
KNSL
$8.93B
| $6.08M | 0.02% |
12,488
-11,108
| -47% | -$4.99M |
|
708
PUT
Targa Resources
TRGP
$62.8B
| $6.05M | 0.02% |
30,200
-6,400
| -17% | -$1.27M |
|
709
Expro Ltd
XPRO
$1.99B
| $6.05M | 0.02% |
+608,531
| New | +$7.5M |
|
710
Americold
COLD
$4.37B
| $5.98M | 0.02% |
278,866
-129,926
| -32% | -$2.82M |
|
711
PUT
Qualcomm
QCOM
$166B
| $5.91M | 0.02% |
38,500
-3,700
| -9% | -$603K |
|
712
CALL
Carpenter Technology
CRS
$23.6B
| $5.85M | 0.02% |
32,300
+1,900
| +6% | +$366K |
|
713
AMN Healthcare
AMN
$1.33B
| $5.85M | 0.02% |
239,117
+205,061
| +602% | +$5.27M |
|
714
Calix
CALX
$2.54B
| $5.84M | 0.02% |
164,701
+13,420
| +9% | +$498K |
|
715
CALL
Hims & Hers Health
HIMS
$7.33B
| $5.82M | 0.02% |
196,900
+78,700
| +67% | +$2.92M |
|
716
T. Rowe Price
TROW
$23.7B
| $5.8M | 0.02% |
+63,079
| New | +$6.67M |
|
717
CALL
Enphase Energy
ENPH
$4.92B
| $5.79M | 0.02% |
93,300
+53,600
| +135% | +$3.39M |
|
718
Artivion
AORT
$1.33B
| $5.78M | 0.02% |
234,989
+57,927
| +33% | +$1.61M |
|
719
Jabil
JBL
$31.9B
| $5.76M | 0.02% |
42,344
-42,765
| -50% | -$6.58M |
|
720
Archer Daniels Midland
ADM
$37.5B
| $5.76M | 0.02% |
+119,973
| New | +$5.8M |
|
721
CALL
CRH
CRH
$63.6B
| $5.74M | 0.02% |
65,200
+59,300
| +1,005% | +$5.83M |
|
722
Invesco S&P 500 Momentum ETF
SPMO
$21.8B
| $5.73M | 0.02% |
61,899
+59,461
| +2,439% | +$5.82M |
|
723
Schwab US Large-Cap Growth ETF
SCHG
$62.2B
| $5.72M | 0.02% |
228,525
-90,841
| -28% | -$2.49M |
|
724
CALL
RH
RH
$2.71B
| $5.72M | 0.02% |
24,400
+19,800
| +430% | +$6.85M |
|
725
PUT
BILL Holdings
BILL
$4.76B
| $5.7M | 0.02% |
124,200
+107,800
| +657% | +$7.25M |
|
Similar funds
Paul Tudor Jones's Q1 2025 Portfolio in Review
As of Q1 2025, Paul Tudor Jones held 3,818 positions worth $30.1B, up 15% from $26.3B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Paul Tudor Jones deployed $6.13B of net new capital in Q1 2025, opening 874 new positions and adding to 1,161 existing holdings. Its largest new stake was Intra-Cellular Therapies Inc.: 621,815 shares worth $82M.
By sector, the portfolio is most concentrated in Technology at 5.9% of assets, down from 6.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares Bitcoin Trust, an estimated $175M trimmed.
- Paul Tudor Jones's largest Q1 2025 buy was Intra-Cellular Therapies Inc.: 621,815 shares worth $82M.
- Paul Tudor Jones added most to iShares Russell 2000 ETF in Q1 2025, an estimated $662M increase.
- Paul Tudor Jones's biggest Q1 2025 reduction was iShares Bitcoin Trust, cutting an estimated $175M.
- Paul Tudor Jones fully exited Infinera Corporation Common Stock in Q1 2025, selling an estimated $108M.
- Paul Tudor Jones's ten largest holdings make up 40% of its $30.1B portfolio in Q1 2025.
- Paul Tudor Jones opened 874 new positions and closed 844 in Q1 2025.
- Paul Tudor Jones's portfolio value rose 15% quarter-over-quarter to $30.1B.
Based on Tudor Investment Corp's 13F filing for Q1 2025, filed 15 May 2025.